Area of research
Oncology · Immunology
Research interest
Research interests include Immunotherapy and Immune Responses, CAR-T cell therapy research, Melanoma and MAPK Pathways, and Cancer Immunotherapy and Biomarkers.
IL-13Rα2/TGF-<b>β</b> bispecific CAR-T cells counter TGF-<b>β</b>-mediated immune suppression and potentiate anti-tumor responses in glioblastoma
Pigs as Clinically Relevant Models for Synergizing Interventional Oncology and Immunotherapy
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance
Tremelimumab: research and clinical development
Combined treatment with dabrafenib and trametinib with immune-stimulating antibodies for BRAF mutant melanoma
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma
Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma
Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes
Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma
Multifunctional T-cell Analyses to Study Response and Progression in Adoptive Cell Transfer Immunotherapy
BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy